Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 201 entries
Sorted by: Best Match Show Resources per page
Nanotechnology enables superior medical therapies.

Current drug delivery

Foldvari M, Elsabahy M.
PMID: 21291383
Curr Drug Deliv. 2011 May;8(3):225-6. doi: 10.2174/156720111795256183.

No abstract available.

Cite
Foldvari M, Elsabahy M. Nanotechnology enables superior medical therapies. Curr Drug Deliv. 2011;8(3):225-6doi: 10.2174/156720111795256183.
Foldvari, M., & Elsabahy, M. (2011). Nanotechnology enables superior medical therapies. Current drug delivery, 8(3), 225-6. https://doi.org/10.2174/156720111795256183
Foldvari, Marianna, and Elsabahy, Mahmoud. "Nanotechnology enables superior medical therapies." Current drug delivery vol. 8,3 (2011): 225-6. doi: https://doi.org/10.2174/156720111795256183
Foldvari M, Elsabahy M. Nanotechnology enables superior medical therapies. Curr Drug Deliv. 2011 May;8(3):225-6. doi: 10.2174/156720111795256183. PMID: 21291383.
Copy Download .nbib Format: NLM
Diabetic cardiomyopathy and metabolic remodeling of the heart.

Life sciences

Battiprolu PK, Lopez-Crisosto C, Wang ZV, Nemchenko A, Lavandero S, Hill JA.
PMID: 23123443
Life Sci. 2013 Mar 28;92(11):609-15. doi: 10.1016/j.lfs.2012.10.011. Epub 2012 Oct 30.

The incidence and prevalence of diabetes mellitus are both increasing rapidly in societies around the globe. The majority of patients with diabetes succumb ultimately to heart disease, much of which stems from atherosclerotic disease and hypertension. However, the diabetic...

Cite
Battiprolu PK, Lopez-Crisosto C, Wang ZV, et al. Diabetic cardiomyopathy and metabolic remodeling of the heart. Life Sci. 2012;92(11):609-15doi: 10.1016/j.lfs.2012.10.011.
Battiprolu, P. K., Lopez-Crisosto, C., Wang, Z. V., Nemchenko, A., Lavandero, S., & Hill, J. A. (2013). Diabetic cardiomyopathy and metabolic remodeling of the heart. Life sciences, 92(11), 609-15. https://doi.org/10.1016/j.lfs.2012.10.011
Battiprolu, Pavan K, et al. "Diabetic cardiomyopathy and metabolic remodeling of the heart." Life sciences vol. 92,11 (2013): 609-15. doi: https://doi.org/10.1016/j.lfs.2012.10.011
Battiprolu PK, Lopez-Crisosto C, Wang ZV, Nemchenko A, Lavandero S, Hill JA. Diabetic cardiomyopathy and metabolic remodeling of the heart. Life Sci. 2013 Mar 28;92(11):609-15. doi: 10.1016/j.lfs.2012.10.011. Epub 2012 Oct 30. PMID: 23123443; PMCID: PMC3593804.
Copy Download .nbib Format: NLM
Nano-enabled drug delivery: a research profile.

Nanomedicine : nanotechnology, biology, and medicine

Zhou X, Porter AL, Robinson DK, Shim MS, Guo Y.
PMID: 24632245
Nanomedicine. 2014 Jul;10(5):889-96. doi: 10.1016/j.nano.2014.03.001. Epub 2014 Mar 12.

UNLABELLED: Nano-enabled drug delivery (NEDD) systems are rapidly emerging as a key area for nanotechnology application. Understanding the status and developmental prospects of this area around the world is important to determine research priorities, and to evaluate and direct...

Cite
Zhou X, Porter AL, Robinson DK, et al. Nano-enabled drug delivery: a research profile. Nanomedicine. 2014;10(5):889-96doi: 10.1016/j.nano.2014.03.001.
Zhou, X., Porter, A. L., Robinson, D. K., Shim, M. S., & Guo, Y. (2014). Nano-enabled drug delivery: a research profile. Nanomedicine : nanotechnology, biology, and medicine, 10(5), 889-96. https://doi.org/10.1016/j.nano.2014.03.001
Zhou, Xiao, et al. "Nano-enabled drug delivery: a research profile." Nanomedicine : nanotechnology, biology, and medicine vol. 10,5 (2014): 889-96. doi: https://doi.org/10.1016/j.nano.2014.03.001
Zhou X, Porter AL, Robinson DK, Shim MS, Guo Y. Nano-enabled drug delivery: a research profile. Nanomedicine. 2014 Jul;10(5):889-96. doi: 10.1016/j.nano.2014.03.001. Epub 2014 Mar 12. PMID: 24632245.
Copy Download .nbib Format: NLM
Small and bright: nanodiamonds for tissue repair, drug delivery, and biodetection.

IEEE pulse

Yang L, Webster TJ.
PMID: 24625589
IEEE Pulse. 2014 Mar-Apr;5(2):34-9. doi: 10.1109/MPUL.2013.2296800.

No abstract available.

Cite
Yang L, Webster TJ. Small and bright: nanodiamonds for tissue repair, drug delivery, and biodetection. IEEE Pulse. 2014;5(2):34-9doi: 10.1109/MPUL.2013.2296800.
Yang, L., & Webster, T. J. (2014). Small and bright: nanodiamonds for tissue repair, drug delivery, and biodetection. IEEE pulse, 5(2), 34-9. https://doi.org/10.1109/MPUL.2013.2296800
Yang, Lei, and Webster, Thomas J. "Small and bright: nanodiamonds for tissue repair, drug delivery, and biodetection." IEEE pulse vol. 5,2 (2014): 34-9. doi: https://doi.org/10.1109/MPUL.2013.2296800
Yang L, Webster TJ. Small and bright: nanodiamonds for tissue repair, drug delivery, and biodetection. IEEE Pulse. 2014 Mar-Apr;5(2):34-9. doi: 10.1109/MPUL.2013.2296800. PMID: 24625589.
Copy Download .nbib Format: NLM
Editorial.

Journal of pharmaceutical sciences

Borchardt RT.
PMID: 29421213
J Pharm Sci. 2018 Apr;107(4):957. doi: 10.1016/j.xphs.2018.01.022. Epub 2018 Feb 05.

No abstract available.

Cite
Borchardt RT. Editorial. J Pharm Sci. 2018;107(4):957doi: 10.1016/j.xphs.2018.01.022.
Borchardt, R. T. (2018). Editorial. Journal of pharmaceutical sciences, 107(4), 957. https://doi.org/10.1016/j.xphs.2018.01.022
Borchardt, Ronald T. "Editorial." Journal of pharmaceutical sciences vol. 107,4 (2018): 957. doi: https://doi.org/10.1016/j.xphs.2018.01.022
Borchardt RT. Editorial. J Pharm Sci. 2018 Apr;107(4):957. doi: 10.1016/j.xphs.2018.01.022. Epub 2018 Feb 05. PMID: 29421213.
Copy Download .nbib Format: NLM
Terminology matters: There is no targeting, but retention.

Journal of controlled release : official journal of the Controlled Release Society

Reineke J.
PMID: 29360476
J Control Release. 2018 Mar 10;273:180-183. doi: 10.1016/j.jconrel.2018.01.016. Epub 2018 Jan 31.

No abstract available.

Cite
Reineke J. Terminology matters: There is no targeting, but retention. J Control Release. 2018;273:180-183doi: 10.1016/j.jconrel.2018.01.016.
Reineke, J. (2018). Terminology matters: There is no targeting, but retention. Journal of controlled release : official journal of the Controlled Release Society, 273180-183. https://doi.org/10.1016/j.jconrel.2018.01.016
Reineke, Joshua. "Terminology matters: There is no targeting, but retention." Journal of controlled release : official journal of the Controlled Release Society vol. 273 (2018): 180-183. doi: https://doi.org/10.1016/j.jconrel.2018.01.016
Reineke J. Terminology matters: There is no targeting, but retention. J Control Release. 2018 Mar 10;273:180-183. doi: 10.1016/j.jconrel.2018.01.016. Epub 2018 Jan 31. PMID: 29360476.
Copy Download .nbib Format: NLM
Posterior drug delivery via periocular route: challenges and opportunities.

Therapeutic delivery

Waite D, Wang Y, Jones D, Stitt A, Raj Singh TR.
PMID: 28730942
Ther Deliv. 2017 Jul;8(8):685-699. doi: 10.4155/tde-2017-0097.

Drug delivery to the posterior segment via the periocular route is a promising route for delivery of a range of formulations. In this review, we have highlighted the challenges and opportunities of posterior segment drug delivery via the periocular...

Cite
Waite D, Wang Y, Jones D, et al. Posterior drug delivery via periocular route: challenges and opportunities. Ther Deliv. 2017;8(8):685-699doi: 10.4155/tde-2017-0097.
Waite, D., Wang, Y., Jones, D., Stitt, A., & Raj Singh, T. R. (2017). Posterior drug delivery via periocular route: challenges and opportunities. Therapeutic delivery, 8(8), 685-699. https://doi.org/10.4155/tde-2017-0097
Waite, David, et al. "Posterior drug delivery via periocular route: challenges and opportunities." Therapeutic delivery vol. 8,8 (2017): 685-699. doi: https://doi.org/10.4155/tde-2017-0097
Waite D, Wang Y, Jones D, Stitt A, Raj Singh TR. Posterior drug delivery via periocular route: challenges and opportunities. Ther Deliv. 2017 Jul;8(8):685-699. doi: 10.4155/tde-2017-0097. PMID: 28730942.
Copy Download .nbib Format: NLM
Editorial: Editors' Collection 2016.

Advanced drug delivery reviews

Ghandehari H.
PMID: 28137361
Adv Drug Deliv Rev. 2017 Jan 01;108:1. doi: 10.1016/j.addr.2017.01.002.

No abstract available.

Cite
Ghandehari H. Editorial: Editors' Collection 2016. Adv Drug Deliv Rev. 2017;108:1doi: 10.1016/j.addr.2017.01.002.
Ghandehari, H. (2017). Editorial: Editors' Collection 2016. Advanced drug delivery reviews, 1081. https://doi.org/10.1016/j.addr.2017.01.002
Ghandehari, Hamidreza. "Editorial: Editors' Collection 2016." Advanced drug delivery reviews vol. 108 (2017): 1. doi: https://doi.org/10.1016/j.addr.2017.01.002
Ghandehari H. Editorial: Editors' Collection 2016. Adv Drug Deliv Rev. 2017 Jan 01;108:1. doi: 10.1016/j.addr.2017.01.002. PMID: 28137361.
Copy Download .nbib Format: NLM
Targeted nanoparticles in pregnancy: a new frontier in perinatal therapeutics.

American journal of obstetrics and gynecology

Refuerzo JS, Longo M, Godin B.
PMID: 28161454
Am J Obstet Gynecol. 2017 Mar;216(3):204-205. doi: 10.1016/j.ajog.2017.01.025. Epub 2017 Feb 02.

No abstract available.

Cite
Refuerzo JS, Longo M, Godin B. Targeted nanoparticles in pregnancy: a new frontier in perinatal therapeutics. Am J Obstet Gynecol. 2017;216(3):204-205doi: 10.1016/j.ajog.2017.01.025.
Refuerzo, J. S., Longo, M., & Godin, B. (2017). Targeted nanoparticles in pregnancy: a new frontier in perinatal therapeutics. American journal of obstetrics and gynecology, 216(3), 204-205. https://doi.org/10.1016/j.ajog.2017.01.025
Refuerzo, Jerrie S, et al. "Targeted nanoparticles in pregnancy: a new frontier in perinatal therapeutics." American journal of obstetrics and gynecology vol. 216,3 (2017): 204-205. doi: https://doi.org/10.1016/j.ajog.2017.01.025
Refuerzo JS, Longo M, Godin B. Targeted nanoparticles in pregnancy: a new frontier in perinatal therapeutics. Am J Obstet Gynecol. 2017 Mar;216(3):204-205. doi: 10.1016/j.ajog.2017.01.025. Epub 2017 Feb 02. PMID: 28161454.
Copy Download .nbib Format: NLM
Global financial challenge: opportunities for strengthening R&D research in targeted drug delivery.

Future medicinal chemistry

Hevey R, Ling CC.
PMID: 22168158
Future Med Chem. 2012 Jan;4(1):1-5. doi: 10.4155/fmc.11.168.

No abstract available.

Cite
Hevey R, Ling CC. Global financial challenge: opportunities for strengthening R&D research in targeted drug delivery. Future Med Chem. 2012;4(1):1-5doi: 10.4155/fmc.11.168.
Hevey, R., & Ling, C. C. (2012). Global financial challenge: opportunities for strengthening R&D research in targeted drug delivery. Future medicinal chemistry, 4(1), 1-5. https://doi.org/10.4155/fmc.11.168
Hevey, Rachel, and Ling, Chang-Chun. "Global financial challenge: opportunities for strengthening R&D research in targeted drug delivery." Future medicinal chemistry vol. 4,1 (2012): 1-5. doi: https://doi.org/10.4155/fmc.11.168
Hevey R, Ling CC. Global financial challenge: opportunities for strengthening R&D research in targeted drug delivery. Future Med Chem. 2012 Jan;4(1):1-5. doi: 10.4155/fmc.11.168. PMID: 22168158.
Copy Download .nbib Format: NLM
DNA Nanocarriers: Programmed to Deliver.

Trends in biochemical sciences

Madhanagopal BR, Zhang S, Demirel E, Wady H, Chandrasekaran AR.
PMID: 30342801
Trends Biochem Sci. 2018 Dec;43(12):997-1013. doi: 10.1016/j.tibs.2018.09.010. Epub 2018 Oct 17.

Simple base-pairing rules of complementarity, perfected by evolution for encoding genetic information, provide unprecedented control over the process of DNA self-assembly. These rules allow us to build exquisite nanostructures and rationally design their morphology, fine-tune their chemical properties, and...

Cite
Madhanagopal BR, Zhang S, Demirel E, et al. DNA Nanocarriers: Programmed to Deliver. Trends Biochem Sci. 2018;43(12):997-1013doi: 10.1016/j.tibs.2018.09.010.
Madhanagopal, B. R., Zhang, S., Demirel, E., Wady, H., & Chandrasekaran, A. R. (2018). DNA Nanocarriers: Programmed to Deliver. Trends in biochemical sciences, 43(12), 997-1013. https://doi.org/10.1016/j.tibs.2018.09.010
Madhanagopal, Bharath Raj, et al. "DNA Nanocarriers: Programmed to Deliver." Trends in biochemical sciences vol. 43,12 (2018): 997-1013. doi: https://doi.org/10.1016/j.tibs.2018.09.010
Madhanagopal BR, Zhang S, Demirel E, Wady H, Chandrasekaran AR. DNA Nanocarriers: Programmed to Deliver. Trends Biochem Sci. 2018 Dec;43(12):997-1013. doi: 10.1016/j.tibs.2018.09.010. Epub 2018 Oct 17. PMID: 30342801.
Copy Download .nbib Format: NLM
Shell buckling: from morphogenesis of soft matter to prospective applications.

Bioinspiration & biomimetics

Lin S, Xie YM, Li Q, Huang X, Zhang Z, Ma G, Zhou S.
PMID: 29923834
Bioinspir Biomim. 2018 Jul 20;13(5):051001. doi: 10.1088/1748-3190/aacdd1.

Being one of the commonest deformation modes for soft matter, shell buckling is the primary reason for the growth and nastic movement of many plants, as well as the formation of complex natural morphology. On-demand regulation of buckling-induced deformation...

Cite
Lin S, Xie YM, Li Q, et al. Shell buckling: from morphogenesis of soft matter to prospective applications. Bioinspir Biomim. 2018;13(5):051001doi: 10.1088/1748-3190/aacdd1.
Lin, S., Xie, Y. M., Li, Q., Huang, X., Zhang, Z., Ma, G., & Zhou, S. (2018). Shell buckling: from morphogenesis of soft matter to prospective applications. Bioinspiration & biomimetics, 13(5), 051001. https://doi.org/10.1088/1748-3190/aacdd1
Lin, Sen, et al. "Shell buckling: from morphogenesis of soft matter to prospective applications." Bioinspiration & biomimetics vol. 13,5 (2018): 051001. doi: https://doi.org/10.1088/1748-3190/aacdd1
Lin S, Xie YM, Li Q, Huang X, Zhang Z, Ma G, Zhou S. Shell buckling: from morphogenesis of soft matter to prospective applications. Bioinspir Biomim. 2018 Jul 20;13(5):051001. doi: 10.1088/1748-3190/aacdd1. PMID: 29923834.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 201 entries